In a regulatory filing, Zenas BioPharma (ZBIO) disclosed that its director Hongbo Lu bought 75K shares of common stock on March 31 in a total transaction size of $1.5M. Shares are up 8.4% afterhours.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZBIO:
- Zenas BioPharma 5M share Spot Secondary priced at $20.00
- Closing Bell Movers: Argan jumps 10% on earnings beat
- Zenas announces common stock, convertible senior notes offerings
- Zenas BioPharma Advances Phase 3 Orelabrutinib Trial in Progressive Multiple Sclerosis
- Zenas BioPharma price target raised to $55 from $45 at Guggenheim